Prevalence of Subtypes of Intestinal Metaplasia in Gastric Antral Mucosa

Overview

Journal Dig Dis Sci

Specialty Gastroenterology

Date 2009 Jan 24

PMID 19160603

Citations 10

Authors

M E Craanen

P Blok

W Dekker

J Ferwerda

G N Tytgat

Affiliations

Soon will be listed here.

Abstract

A prospective gastroscopic-bioptic study of 533 patients was performed to assess the prevalence and distribution of intestinal metaplasia (IM) and its subtypes in the antral mucosa of patients with various upper intestinal disorders and to assess whether the presence of certain IM subtypes might be of help in selecting patients for careful endoscopic-bioptic surveillance in the screening for gastric carcinoma. IM was found in 135 patients (25.3%). Its prevalence increased with age (P < 0.001) and was strongly associated with intestinal-type carcinoma as compared to diffuse-type carcinoma (P < 0.001), gastritis (P < 0.001), and gastric ulcer (P < 0.05). Type I IM was predominant (98.5%), whereas types II and III IM, respectively, were found in 77.8% and 15.6% of the patients with IM. No difference in the prevalence of type I and II IM was found among the various gastric disease states. Type III IM was strongly associated with intestinal-type carcinoma as compared to either benign lesions (P < 0.01) or diffuse-type carcinoma. These results suggest that type III IM may play a special role in the histogenesis of intestinal-type carcinoma and suggest that the finding of this IM subtype in gastric biopsies may possibly be of help in identifying patients at greater risk of developing carcinoma.

Citing Articles

Global prevalence of gastric intestinal metaplasia: a systematic review and meta-analysis.

Soroorikia S, Kazeminia M, Qaderi K, Ziapour A, Hodhodi T, Javanbakht Z Syst Rev. 2024; 13(1):247.

PMID: 39342409 PMC: 11439247. DOI: 10.1186/s13643-024-02633-x.

A meta-analysis and systematic review on subtypes of gastric intestinal metaplasia and neoplasia risk.

Wei N, Zhou M, Lei S, Zhong Z, Shi R Cancer Cell Int. 2021; 21(1):173.

PMID: 33731114 PMC: 7968216. DOI: 10.1186/s12935-021-01869-0.

Advancing the Science in Gastric Pre-Neoplasia: Study Design Considerations.

Davitkov P, Altayar O, Shah S, Gawron A, Mustafa R, Sultan S Gastroenterology. 2019; 158(3):751-759.

PMID: 31887260 PMC: 7354093. DOI: 10.1053/j.gastro.2019.12.005.

AGA Technical Review on Gastric Intestinal Metaplasia-Epidemiology and Risk Factors.

Altayar O, Davitkov P, Shah S, Gawron A, Morgan D, Turner K Gastroenterology. 2019; 158(3):732-744.e16.

PMID: 31816301 PMC: 7425600. DOI: 10.1053/j.gastro.2019.12.002.

Utility of subtyping intestinal metaplasia as marker of gastric cancer risk. A review of the evidence.

Gonzalez C, Sanz-Anquela J, Gisbert J, Correa P Int J Cancer. 2013; 133(5):1023-32.

PMID: 23280711 PMC: 3732516. DOI: 10.1002/ijc.28003.

References

Sipponen P, Kekki M, Haapakoski J, Ihamaki T, Siurala M . Gastric cancer risk in chronic atrophic gastritis: statistical calculations of cross-sectional data. Int J Cancer. 1985; 35(2):173-7. DOI: 10.1002/ijc.2910350206. View

Sipponen P, Kekki M, Siurala M . Atrophic chronic gastritis and intestinal metaplasia in gastric carcinoma. Comparison with a representative population sample. Cancer. 1983; 52(6):1062-8. DOI: 10.1002/1097-0142(19830915)52:6<1062::aid-cncr2820520622>3.0.co;2-p. View

Matsukura N, Suzuki K, Kawachi T, Aoyagi M, Sugimura T, Kitaoka H . Distribution of marker enzymes and mucin in intestinal metaplasia in human stomach and relation to complete and incomplete types of intestinal metaplasia to minute gastric carcinomas. J Natl Cancer Inst. 1980; 65(2):231-40. View

LAUREN P . THE TWO HISTOLOGICAL MAIN TYPES OF GASTRIC CARCINOMA: DIFFUSE AND SO-CALLED INTESTINAL-TYPE CARCINOMA. AN ATTEMPT AT A HISTO-CLINICAL CLASSIFICATION. Acta Pathol Microbiol Scand. 1965; 64:31-49. DOI: 10.1111/apm.1965.64.1.31. View

Hirota T, Itabashi M, Suzuki K, Yoshida S . Clinicopathologic study of minute and small early gastric cancer. Histogenesis of gastric cancer. Pathol Annu. 1980; 15(Pt 2):1-19. View

Jass J . Role of intestinal metaplasia in the histogenesis of gastric carcinoma. J Clin Pathol. 1980; 33(9):801-10. PMC: 1146235. DOI: 10.1136/jcp.33.9.801. View

Correa P . The epidemiology and pathogenesis of chronic gastritis: three etiologic entites. Front Gastrointest Res. 1980; 6:98-108. DOI: 10.1159/000403325. View

STEMMERMANN G, Hayashi T . Intestinal metaplasia of the gastric mucosa: a gross and microscopic study of its distribution in various disease states. J Natl Cancer Inst. 1968; 41(3):627-34. View

Rhodes J . Colonic mucus and mucosal glycoproteins: the key to colitis and cancer?. Gut. 1989; 30(12):1660-6. PMC: 1434463. DOI: 10.1136/gut.30.12.1660. View

10.

Jass J, FILIPE M . A variant of intestinal metaplasia associated with gastric carcinoma: a histochemical study. Histopathology. 1979; 3(3):191-9. DOI: 10.1111/j.1365-2559.1979.tb02996.x. View

11.

Davessar K, Pezzullo J, Kessimian N, Hale J, Jauregui H . Gastric adenocarcinoma: prognostic significance of several pathologic parameters and histologic classifications. Hum Pathol. 1990; 21(3):325-32. DOI: 10.1016/0046-8177(90)90234-v. View

12.

Duarte I, Fonk M, Llanos O, Guzman S . Intestinal metaplasia of the gastric mucosa in autopsies of Chilean adults. Pathol Res Pract. 1984; 178(6):538-42. DOI: 10.1016/S0344-0338(84)80085-0. View

13.

Craanen M, Dekker W, Ferwerda J, Blok P, Tytgat G . Early gastric cancer: a clinicopathologic study. J Clin Gastroenterol. 1991; 13(3):274-83. DOI: 10.1097/00004836-199106000-00006. View

14.

de Silva H, Millard P, Kettlewell M, Mortensen N, Prince C, Jewell D . Mucosal characteristics of pelvic ileal pouches. Gut. 1991; 32(1):61-5. PMC: 1379215. DOI: 10.1136/gut.32.1.61. View

15.

Imai T, Murayama H . Time trend in the prevalence of intestinal metaplasia in Japan. Cancer. 1983; 52(2):353-61. DOI: 10.1002/1097-0142(19830715)52:2<353::aid-cncr2820520229>3.0.co;2-3. View

16.

Huang C, Xu J, Huang J, Meng X . Sulphomucin colonic type intestinal metaplasia and carcinoma in the stomach. A histochemical study of 115 cases obtained by biopsy. Cancer. 1986; 57(7):1370-5. DOI: 10.1002/1097-0142(19860401)57:7<1370::aid-cncr2820570721>3.0.co;2-j. View

17.

FILIPE M . Mucins in the human gastrointestinal epithelium: a review. Invest Cell Pathol. 1979; 2(3):195-216. View

18.

Sipponen P . Intestinal metaplasia and gastric carcinoma. Ann Clin Res. 1981; 13(3):139-43. View

19.

FILIPE M, POTET F, Bogomoletz W, Dawson P, Fabiani B, Chauveinc P . Incomplete sulphomucin-secreting intestinal metaplasia for gastric cancer. Preliminary data from a prospective study from three centres. Gut. 1985; 26(12):1319-26. PMC: 1433103. DOI: 10.1136/gut.26.12.1319. View

20.

. Screening for gastric cancer in the West. Lancet. 1978; 1(8072):1023-4. View